ArticleJapanese journal of clinical oncology2021

Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.

Hiroshi Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.